← Back to Search

MyChart Tool for Type 1 Diabetes Care

Q: Does eligibility for this study extend to geriatric patients?

As stipulated in the study's criteria for inclusion, any person aged between 0 and 131 months is eligible to participate.

Q: How many individuals are presently receiving treatment within this medical experiment?

Affirmative. Information presented on clinicaltrials.gov indicates that this research initiative is presently enrolling participants, with the original posting date of April 3rd 2023 and a recent update of July 27th 2023. 200 test subjects are required from one distinct medical facility.

Q: Is there still availability to participate in this research initiative?

The clinical trial is currently open for recruitment, as indicated by the facts hosted on clinicialtrials.gov. This medical study was initially published on April 3rd 2023 and had its most recent update recorded at July 27th 2023.

Q: What type of individuals are ideal for inclusion in this research endeavor?

In order to qualify for participation, potential participants must have <a href="https://www.withpower.com/clinical-trials/type-1-diabetes">type 1 diabetes</a> and be between 0-131 months old. The total number of enrollees expected is 200 individuals.

N/A

Recruiting

Research Sponsored by Children's Hospital of Eastern Ontario

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Diagnosis of T1D

Age <11 years at enrollment

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 months

Awards & highlights

Study Summary

This trial is testing a tool to let patients input diabetes info into their doctor's electronic health record before their visit, to improve the quality of diabetes care.

Who is the study for?

This trial is for children under 11 years old with Type 1 Diabetes. They must be fluent in English and able to give consent. It's not open to those followed in Eating Disorder or Child and Youth Protection Clinics, or kids who are 11 or older.Check my eligibility

What is being tested?

The study tests a MyChart Questionnaire that lets families enter diabetes-related info into their doctor's records before the clinic visit. The goal is to see if this improves care quality, diabetes control, and clinic efficiency.See study design

What are the potential side effects?

Since this intervention involves using an electronic questionnaire rather than medication, there are no direct medical side effects; however, technical issues or data entry errors could potentially occur.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have been diagnosed with Type 1 Diabetes.

Select...

I am younger than 11 years old.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Participant Tool and Workflow Survey

Patients' Evaluation of Quality of Diabetes Care (PEQD)

Perceived Quality of Medical Care (PQMC)

+1 more

Secondary outcome measures

To evaluate the impact of a patient-facing EHR-enabled questionnaire on glycemic control and visit efficiency.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: MyChart Questionnaire (Intervention Group)Experimental Treatment1 Intervention

Participants within the intervention group will complete the patient-facing EHR-enabled MyChart® questionnaire.

Group II: Standard Clinical Care (Control Group)Active Control1 Intervention

Participants within the control group will undergo standard clinical care with no study intervention.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Children's Hospital of Eastern OntarioLead Sponsor

126 Previous Clinical Trials

55,282 Total Patients Enrolled

Media Library

MyChart Questionnaire (Intervention Group) Clinical Trial Eligibility Overview. Trial Name: NCT05979077 — N/A

Type 1 Diabetes Research Study Groups: MyChart Questionnaire (Intervention Group), Standard Clinical Care (Control Group)

Type 1 Diabetes Clinical Trial 2023: MyChart Questionnaire (Intervention Group) Highlights & Side Effects. Trial Name: NCT05979077 — N/A

MyChart Questionnaire (Intervention Group) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05979077 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does eligibility for this study extend to geriatric patients?

"As stipulated in the study's criteria for inclusion, any person aged between 0 and 131 months is eligible to participate."

Answered by AI

How many individuals are presently receiving treatment within this medical experiment?

"Affirmative. Information presented on clinicaltrials.gov indicates that this research initiative is presently enrolling participants, with the original posting date of April 3rd 2023 and a recent update of July 27th 2023. 200 test subjects are required from one distinct medical facility."

Answered by AI

Is there still availability to participate in this research initiative?

"The clinical trial is currently open for recruitment, as indicated by the facts hosted on clinicialtrials.gov. This medical study was initially published on April 3rd 2023 and had its most recent update recorded at July 27th 2023."

Answered by AI

What type of individuals are ideal for inclusion in this research endeavor?

"In order to qualify for participation, potential participants must have type 1 diabetes and be between 0-131 months old. The total number of enrollees expected is 200 individuals."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Children's Hospital Academic Medical Organization (CHAMO) MyChart Study

Ellen Goldbloom 2023. "Children's Hospital Academic Medical Organization (CHAMO) MyChart Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05979077.

All > Type 1 Diabetes